The World Health Organization ranks Saudi Arabia as having the 7th highest rate of type-2 diabetes in the world. This therefore makes diabetes the most challenging health problem facing Saudi Arabia. Importantly, physical activity has been shown to improve disease symptoms and overall health in patients with type-2 diabetes. However, findings relating to the prevalence of physical inactivity in the Saudi population confirm that a sedentary lifestyle is on the rise, within physical inactivity levels in adults being 80.5%. Therefore, interventions aimed at reducing physical inactivity using bespoke modalities pertinent to Saudi Arabia are clearly warranted. The purpose of this research project is to undertake a feasibility randomised control trial, examining the effects of a 12-week home-based physical activity programme on HbA1c, blood lipids, fasting glucose and other indices of health-related quality of life in Saudi Arabian adults with type-2 diabetes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
62
Participants will be asked to perform resistance exercises 3-times a week on alternating days for 12 weeks. Exercises will be performed with a TheraBand and will include the squat, lunge, press-up, cross body reach, reverse fly, lateral raise, biceps curl, triceps extension, frontal raise and bridge. In addition to the resistance exercises, the participants will perform aerobic exercise. They will be asked to download a specific exercise app to record the number of steps on day 1 of the intervention and participants who do not possess the required phone technology will be provided with a pedometer. They then will be asked to add 2000 steps on to their daily steps; this amount will then become their daily step goal. Once they have reached this goal on 4 out of 5 days, they will be asked to increase their new step step goal by an extra 500 per day.
Usual care.
Jazan Diabetes Centre
Jizan, Saudi Arabia
HBA1c (Glycated hemoglobin)
Glycated hemoglobin is a form of hemoglobin that is chemically linked to a sugar. This parameter will be obtained via a venous blood sample.
Time frame: Baseline
HBA1c (Glycated hemoglobin)
Glycated hemoglobin is a form of hemoglobin that is chemically linked to a sugar. This parameter will be obtained via a venous blood sample.
Time frame: 12 weeks
HBA1c (Glycated hemoglobin)
Glycated hemoglobin is a form of hemoglobin that is chemically linked to a sugar. This parameter will be obtained via a venous blood sample.
Time frame: 24 weeks
WHO Well-Being Index (WHO-5)
The World Health Organisation- Five Well-Being Index (WHO-5) is a short self-reported measure of current mental wellbeing. A score of 0 represents the worst imaginable well-being and 100 represents the best imaginable well-being.
Time frame: Baseline
WHO Well-Being Index (WHO-5)
The World Health Organisation- Five Well-Being Index (WHO-5) is a short self-reported measure of current mental wellbeing. A score of 0 represents the worst imaginable well-being and 100 represents the best imaginable well-being.
Time frame: 12 weeks
WHO Well-Being Index (WHO-5)
The World Health Organisation- Five Well-Being Index (WHO-5) is a short self-reported measure of current mental wellbeing. A score of 0 represents the worst imaginable well-being and 100 represents the best imaginable well-being.
Time frame: 24 weeks
Patient Health Questionnaire-9 (PHQ-9)
The Patient Health Questionnaire-9 (PHQ-9) is the depression module, which has nine questions ranging from "0" (not at all) to "3" (nearly every day). The scoring is interpreted as 0-4 no depression symptoms, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe depression symptoms.
Time frame: Baseline
Patient Health Questionnaire-9 (PHQ-9)
The Patient Health Questionnaire-9 (PHQ-9) is the depression module, which has nine questions ranging from "0" (not at all) to "3" (nearly every day). The scoring is interpreted as 0-4 no depression symptoms, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe depression symptoms.
Time frame: 12 weeks
Patient Health Questionnaire-9 (PHQ-9)
The Patient Health Questionnaire-9 (PHQ-9) is the depression module, which has nine questions ranging from "0" (not at all) to "3" (nearly every day). The scoring is interpreted as 0-4 no depression symptoms, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe depression symptoms.
Time frame: 24 weeks
Pittsburgh Sleep Quality Index (PSQI)
The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality. The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality.
Time frame: Baseline
Pittsburgh Sleep Quality Index (PSQI)
The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality. The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality.
Time frame: 12 weeks
Pittsburgh Sleep Quality Index (PSQI)
The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality. The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality.
Time frame: 24 weeks
Physical fitness
Physical fitness will be examined via the Chester Step test.
Time frame: Baseline
Physical fitness
Physical fitness will be examined via the Chester Step test.
Time frame: 12 weeks
Physical fitness
Physical fitness will be examined via the Chester Step test.
Time frame: 24 weeks
Fasting glucose
Fasting glucose levels will be examined via a venous blood sample.
Time frame: Baseline
Fasting glucose
Fasting glucose levels will be examined via a venous blood sample.
Time frame: 12 weeks
Fasting glucose
Fasting glucose levels will be examined via a venous blood sample.
Time frame: 24 weeks
Systolic blood pressure
Systolic blood pressure using blood pressure monitor with blood pressure cuff on the arm.
Time frame: Baseline
Systolic blood pressure
Systolic blood pressure using blood pressure monitor with blood pressure cuff on the arm.
Time frame: 12 weeks
Systolic blood pressure
Systolic blood pressure using blood pressure monitor with blood pressure cuff on the arm.
Time frame: 24 weeks
Diastolic blood pressure
Diastolic blood pressure using blood pressure monitor with blood pressure cuff on the arm.
Time frame: Baseline
Diastolic blood pressure
Diastolic blood pressure using blood pressure monitor with blood pressure cuff on the arm.
Time frame: 12 weeks
Diastolic blood pressure
Diastolic blood pressure using blood pressure monitor with blood pressure cuff on the arm.
Time frame: 24 weeks
Lipid profile
A full lipid profile will be undertaken this involves Low-density lipoprotein (LDL), High-density lipoprotein (HDL), Triglycerides and Total cholesterol levels. This will be examined via a venous blood sample.
Time frame: Baseline
Lipid profile
A full lipid profile will be undertaken this involves Low-density lipoprotein (LDL), High-density lipoprotein (HDL), Triglycerides and Total cholesterol levels. This will be examined via a venous blood sample.
Time frame: 12 weeks
Lipid profile
A full lipid profile will be undertaken this involves Low-density lipoprotein (LDL), High-density lipoprotein (HDL), Triglycerides and Total cholesterol levels. This will be examined via a venous blood sample.
Time frame: 24 weeks
Body mass
Body mass in kg measured via an electric scale.
Time frame: Baseline
Body mass
Body mass in kg measured via an electric scale.
Time frame: 12 weeks
Body mass
Body mass in kg measured via an electric scale.
Time frame: 24 weeks
Body mass index
Body mass index will be quantified using the standard body mass index equation using measures of body mass and stature.
Time frame: Baseline
Body mass index
Body mass index will be quantified using the standard body mass index equation using measures of body mass and stature.
Time frame: 12 weeks
Body mass index
Body mass index will be quantified using the standard body mass index equation using measures of body mass and stature.
Time frame: 24 weeks
Triglyceride-glucose index
The triglyceride-glucose index will be calculated using a logarithm of the fasting triglyceride and glucose indices.
Time frame: Baseline
Triglyceride-glucose index
The triglyceride-glucose index will be calculated using a logarithm of the fasting triglyceride and glucose indices.
Time frame: 12 weeks
Triglyceride-glucose index
The triglyceride-glucose index will be calculated using a logarithm of the fasting triglyceride and glucose indices.
Time frame: 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.